share_log

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Aldag Jorn

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Aldag Jorn

HOOKIPA Pharma | 4:持股变动声明-高管 Aldag Jorn
美股sec公告 ·  04/17 16:20
Moomoo AI 已提取核心信息
Jorn Aldag, the Chief Executive Officer of HOOKIPA Pharma Inc. (ticker symbol: HOOK), was involved in a transaction with the company's shares on April 15, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within HOOKIPA Pharma and may influence their investment decisions.
Jorn Aldag, the Chief Executive Officer of HOOKIPA Pharma Inc. (ticker symbol: HOOK), was involved in a transaction with the company's shares on April 15, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within HOOKIPA Pharma and may influence their investment decisions.
HOOKIPA Pharma Inc.(股票代码:HOOK)首席执行官乔恩·阿尔达格于2024年4月15日参与了该公司股票的交易。公告中未披露交易的具体细节,例如行动类型、状态、股票数量、股票性质、交易价格和交易后持有量。这些信息对于投资者了解HOOKIPA Pharma内部活动至关重要,并可能影响他们的投资决策。
HOOKIPA Pharma Inc.(股票代码:HOOK)首席执行官乔恩·阿尔达格于2024年4月15日参与了该公司股票的交易。公告中未披露交易的具体细节,例如行动类型、状态、股票数量、股票性质、交易价格和交易后持有量。这些信息对于投资者了解HOOKIPA Pharma内部活动至关重要,并可能影响他们的投资决策。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息